EMPOWER-Lung 1: Phase III first-line (1L) cemiplimab monotherapy vs platinum-doublet chemotherapy (chemo) in advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) >= 50%

Sezer A., Kilickap S., Gumus M., Bondarenko I., ÖZGÜROĞLU M., Gogishvili M., ...More

ESMO Virtual Congress, ELECTR NETWORK, 19 September - 18 October 2020, vol.31, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Volume: 31
  • Doi Number: 10.1016/j.annonc.2020.08.2285
  • Country: ELECTR NETWORK
  • Istanbul University Affiliated: No